Jared Gichohi Maina

Jared Gichohi Maina

Auto-generated profile, based on publicly available information

Jared Gichohi Maina

Social, Genetic and Developmental Psychiatry Centre, King's College London, London, UK

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KDKatrina A.S. Davis
Katrina A.S. Davis
Jonathan ColemanJonathan Coleman
Jonathan Coleman
MAMark Adams
Mark Adams
GBGerome Breen
Gerome Breen
NCNa Cai
Na Cai
MHMatthew Hotopf
Matthew Hotopf
Background: This paper introduces the UK Biobank (UKB) second mental health questionnaire (MHQ2), describes its design, the respondents and some notable findings. UKB is a large cohort study with over 500,000 volunteer participants aged 40–69 years when recruited in 2006–2010. It is an important resource of extensive health, genetic and biomarker data. Enhancements to UKB enrich the data available. MHQ2 is an enhancement designed to enable and facilitate research with psychosocial and mental health aspects. Methods: UKB sent participants a link to MHQ2 by email in October-November 2022. The MHQ2 was designed by a multi-institutional consortium to build on MHQ1. It characterises lifetime depression further, adds data on panic disorder and eating disorders, repeats ‘current’ mental health measures and updates information about social circumstances. It includes established measures, such as the PHQ-9 for current depression and CIDI-SF for lifetime panic, as well as bespoke questions. Algorithms and R code were developed to facilitate analysis. Results: At the time of analysis, MHQ2 results were available for 169,253 UKB participants, of whom 111,275 had also completed the earlier MHQ1. Characteristics of respondents and the whole UKB cohort are compared. The major phenotypes are lifetime: depression (18%); panic disorder (4.0%); a specific eating disorder (2.8%); and bipolar affective disorder I (0.4%). All mental disorders are found less with older age and also seem to be related to selected social factors. In those participants who answered both MHQ1 (2016) and MHQ2 (2022), current mental health measure showed that fewer respondents have harmful alcohol use than in 2016 (relative risk 0.84), but current depression (RR 1.07) and anxiety (RR 0.98) have not fallen, as might have been expected given the relationship with age. We also compare lifetime concepts for test-retest reliability. Conclusions: There are some drawbacks to UKB due to its lack of population representativeness, but where the research question does not depend on this, it offers exceptional resources that any researcher can apply to access. This paper has just scratched the surface of the results from MHQ2 and how this can be combined with other tranches of UKB data, but we predict it will enable many future discoveries about mental health and health in general.

6 October 2025 in Wellcome Open Research
Verified
Journal Article
Open access
AOAdeniran Okewole
Adeniran Okewole
JMJared G. Maina
Jared G. Maina
WNWisdom P. Nakanga
Wisdom P. Nakanga
VCVivien J. Chebii
Vivien J. Chebii
NSNatalie Smyth
Natalie Smyth
AMAndrew M. McIntosh
Andrew M. McIntosh
Background Major Depressive Disorder (MDD) is a disabling condition that arises from the interplay of genetic and environmental risk factors. Most genetic studies of depression to date have failed to include continental African populations. As a result, risk-associated genetic variation among African populations remains undiscovered, and its potential specificity and interactions with environmental factors are unclear. Methods Here presented is the study protocol for the Depression Genetics in Africa (DepGenAfrica) study, which aims to 1) characterise depressive syndromes and identify the genetic architecture of MDD in 12,000 individuals (8000 cases and 4000 controls) living in Western (Nigeria), Eastern (Ethiopia) and Southern (Malawi) Africa through new data collections and collaborations with existing and ongoing projects; 2) compare the symptoms, associations and genetic architectures of MDD with other African and European ancestry populations to build a more complete global picture of its aetiology; and 3) perform downstream analyses of African MDD genetic data to investigate underlying biology and risk factors. The phenotyping battery and the data and blood sample handling procedures are outlined. Discussion The DepGenAfrica study will help fill the substantial gap in the understanding of risk mechanisms, natural clinical course and outcomes of MDD in continental African individuals. This will enhance global understanding and ensure that Africans can benefit from risk prediction algorithms, early intervention and therapeutic (including pharmacogenomic) strategies.

5 February 2026 in Behavior Genetics
Verified
Journal Article
Open access
HDHelena L. Davies
Helena L. Davies
NRNiamh M. Ryan
Niamh M. Ryan
KRKylie K. Reed
Kylie K. Reed
NBNatasha Berthold
Natasha Berthold
JMJared G. Maina
Jared G. Maina
HEHoward J. Edenberg
Howard J. Edenberg
Outreach in psychiatric genetics bridges the gaps across research advancements, clinical practice, and public understanding. Effective communication with a range of audiences faces multiple challenges, including the complex nature of psychiatric disorders and of genetic findings, the chronicled and ongoing misuse of genetic data, and the rapid growth of direct-to-consumer genetic testing. This is particularly true in the internet and social media era, which has accelerated the spread of inaccurate information with serious consequences, including perpetuating stigma and increasing shame. Yet a significant gap remains in outreach: a recent survey found that only 51% of psychiatric genetics researchers participate in outreach, largely attributed to their perceived lack of skill and support. The Psychiatric Genomics Consortium (PGC) developed an Outreach Committee to organize and catalyze initiatives including: the Worldwide Lab, an online seminar series covering new and important approaches that is then posted on YouTube; the PGC Video Textbook, which has resources for clinicians, researchers, educators, and the broader public; patient and family engagement programs; and social media campaigns designed to inform both researchers and affected communities about new developments in psychiatric genetics. These initiatives were developed to demystify psychiatric genetics research and empower broad audiences with reliable, actionable information. Along with research and traditional teaching, the psychiatric genomics community should continue to prioritize and recognize engagement as a core component of our academic mission and values.

6 March 2025 in medRxiv
Verified
Preprint
Open access
PDF file
VPVincent Pascat
Vincent Pascat
LZLiudmila Zudina
Liudmila Zudina
LMLucas Maurin
Lucas Maurin
AUAnna Ulrich
Anna Ulrich
JMJared G. Maina
Jared G. Maina
IPInga Prokopenko
Inga Prokopenko
Summary: Type 2 diabetes (T2D) and hypertension are common health conditions that often occur together, suggesting shared biological mechanisms. To explore this relationship, we analysed large-scale multiomic data to uncover genetic factors underlying T2D and blood pressure (BP) comorbidity. We curated 1,304 independent single-nucleotide variants (SNVs) associated with T2D/BP, grouping them into five clusters related to metabolic syndrome, inverse T2D-BP risk, impaired pancreatic beta-cell function, higher adiposity, and vascular dysfunction . Colocalisation with tissue-specific gene expression highlighted significant enrichment in pathways related to thyroid function and fetal development. Partitioned polygenic scores (PGS) derived from these clusters improved risk prediction for T2D-hypertension comorbidity, identifying individuals with more than twice usual susceptibility. These results reveal complex genetic basis of shared T2D and BP mechanistic heterogeneity, enhancing comorbidity risk prediction. Partitioned PGSs offer promising approach for early risk stratification, personalised prevention, and improved management of these interconnected conditions, supporting precision medicine and public health initiatives.

23 March 2026 in The British Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
JMJared G. Maina
Jared G. Maina
AOAdeniran Okewole
Adeniran Okewole
BMBarkot Milkias
Barkot Milkias
NSNatalie Smyth
Natalie Smyth
JWJames Walters
James Walters
AMAndrew McIntosh
Andrew McIntosh
Summary: The Depression Genetics in Africa (DepGenAfrica) study seeks to address the underrepresentation of African populations in psychiatric genomics by investigating the genetic basis of major depressive disorder in three African countries: Ethiopia, Malawi and Nigeria. This Editorial reflects on lessons from project set-up and offers recommendations, highlighting trust, communication, ethical oversight, data tools, workforce training and resource governance.

7 April 2026
Verified
Thesis
Closed access
JMJared Maina
Jared Maina
Disséquer les facteurs génétiques contribuant à la prédisposition partagée à l'obésité et au cancer: L'obésité est une affection courante et complexe qui pose de graves problèmes de santé dans le monde entier. Elle est également un facteur de risque critique connu pour certaines maladies non transmissibles, dont les cancers. Différentes mesures anthropométriques telles que l'indice de masse corporelle (IMC) et le rapport taille hanche (RTH) ont été utilisées pour évaluer l'obésité. Ce dernier est un indice de l'obésité centrale ou abdominale, tandis que le premier représente l'obésité totale ou globale. Des études épidémiologiques fournissent des preuves que les mesures de l'obésité centrale et de l'obésité globale peuvent avoir un rapport différent avec le risque de cancer. Les mécanismes physiologiques exacts qui permettent la comorbidité entre l'obésité et le cancer restent flous. Cependant, certains facteurs tels que les facteurs de croissance analogues à l'insuline, l'hyperglycémie, la dérégulation du profil lipidique et les facteurs adipokines ont fait l'objet d'hypothèses. Les études d'association pangénomique (GWAS) ont identifié de nombreuses variations génétiques communes pour les phénotypes de l'obésité et du cancer. Cependant, cesvariations ne fournissent que de modestes indices sur la comorbidité sous-jacente.Néanmoins, les résultats des études d'association pangénomique peuvent être appliqués à des méthodes statistiques telles que les scores polygéniques et la randomisation Mendélienne (MR) qui aident à démêler les déterminants communs.Dans ce projet de doctorat, j'ai évalué l'impact de l'obésité globale et centrale sur le risque de cancers, notamment le cancer du sein, le cancer du sein postménopausique,le cancer de la prostate, le cancer colorectal, le cancer du poumon et le cancer du pancréas. J'ai défini la corrélation génétique entre l'IMC/l’RTH et les cancers en utilisant l'ensemble des données de la UK Biobank. J'ai ensuite utilisé des loci génomiques établis pour l'IMC et l’RTH afin de créer des scores polygéniques d'obésité dont l'association avec les phénotypes de cancer a ensuite été testée dans la UK Biobank. En outre, à l'aide de variantes génétiques établies associées à ces phénotypes, j'ai effectué une MR entre les deux phénotypes d'obésité et trois cancers(sein, prostate et colorectal) afin d'étudier les relations causales entre eux.